COMMUNIQUÉS West-GlobeNewswire

Achaogen Announces FDA Acceptance of New Drug Application with Priority Review for Plazomicin for Treatment of Complicated Urinary Tract Infections and Bloodstream Infections

02/01/2018 - 14:01

-- Investigational drug has potential to treat certain MDR gram-negative pathogens, including carbapenem-resistant Enterobacteriaceae (CRE) -- -- FDA sets action date of June 25, 2018 -- SOUTH SAN FRANCISCO, Calif., Jan [...]

Achaogen Announces Positive Top-Line Results from First Clinical Trial of Orally-Administered Antibacterial Candidate C-Scape

02/01/2018 - 14:01

-- C-Scape was well tolerated across all doses studied in Phase 1 trial, with no drug-drug interaction between the previously approved compounds when dosed in combination -- -- C-Scape is a combination of ceftibuten and [...]

BIOLIFE4D Names Dr. Ravi Birla as its Chief Science Officer

02/01/2018 - 14:01

CHICAGO, Jan. 02, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D , a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has named Dr. Ravi Birla as its Chief [...]

Selecta Biosciences Announces CEO’s Intent to Retire and Transition Plan

02/01/2018 - 14:00

Dr. Werner Cautreels Plans Retirement at the End of 2018 Dr. Omid Farokhzad Appointed Chairman of the Board WATERTOWN, Mass., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB ), a clinical-stage [...]

Inovio Enters License and Collaboration Agreement with ApolloBio To Develop and Commercialize VGX-3100 in Greater China

02/01/2018 - 14:00

PLYMOUTH MEETING, Pa., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO ) today announced that it entered an amended agreement providing ApolloBio Corporation (NEEQ:430187) with the exclusive [...]

PositiveID Corporation Discusses 2017 Accomplishments in New Interview with CEOLIVE.TV

02/01/2018 - 14:00

DELRAY BEACH, Fla., Jan. 02, 2018 (GLOBE NEWSWIRE) -- PositiveID Corporation (the “Company”) (OTC:PSID), a life sciences company focused on detection and diagnostics, announced today that its Chairman and CEO, William J [...]

Avenue Therapeutics Announces Dosing of First Patient in Phase 3 Safety Trial of Intravenous Tramadol for the Management of Postoperative Pain

02/01/2018 - 14:00

NEW YORK, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ: ATXI ) (“Avenue”), a company focused on the development and commercialization of intravenous (IV) tramadol, today announced that it has [...]

WishBone Medical, Inc. Releases Broken Screw Removal and K-Wire Systems

02/01/2018 - 14:00

WARSAW, Ind., Jan. 02, 2018 (GLOBE NEWSWIRE) -- WishBone Medical, Inc., a new global pediatric orthopedic company, has announced the official launch of the single-use, sterile packed Broken Screw Removal and K-Wire [...]

Nuvus Blockchain Building the New Global Exchange Platform for Medical Cannabis Industry with Nuvus Protocol is Raising $100M Through its Upcoming ICO & Token Sale & is Currently Accepting Whitelist Registration

02/01/2018 - 14:00

Saint Petersburg, FL, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Nuvus Blockchain ( https://www.nuvus.io ), a Nuvus Corp company, formed to build the New Global Exchange Platform with big data and supply chain verification [...]

Golden Leaf Announces Closing of Acquisition of Medical Marijuana Group Consulting Ltd.

02/01/2018 - 14:00

TORONTO, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company built around recognized brands, is pleased to announce that [...]

AnaptysBio Announces Presentation at the J.P. Morgan 36th Annual Healthcare Conference

02/01/2018 - 12:30

SAN DIEGO, Jan. 02, 2018 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB ), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation [...]

Transactions in relation to share buyback program

02/01/2018 - 12:22

Acting under its share buyback authorization, the GN Store Nord board of directors initiated a share buyback program on May 4, 2017 in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]

ContraVir Pharmaceuticals to Present at Biotech Showcase 2018

02/01/2018 - 12:00

EDISON, N.J., Jan. 02, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced [...]

BeiGene Initiates Global Phase 3 Trial of Anti-PD-1 Antibody Tislelizumab in Patients with Hepatocellular Carcinoma

02/01/2018 - 12:00

CAMBRIDGE, Mass. and BEIJING, China, Jan. 02, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE ), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly [...]

Novo Nordisk A/S: Status regarding Novo Nordisk's holding of its own shares (31 December 2017)

02/01/2018 - 11:15

Bagsværd, Denmark, 2 January 2018 - In continuation of the company's announcements dated 9 August 2017 and 1 November 2017 concerning planned share repurchase programmes, and pursuant to Section 204.25 of the New York [...]

HealthLynked Corp. Announces release of its Medical Newsfeed Service for Members and Providers

02/01/2018 - 11:00

NAPLES, Fla., Jan. 02, 2018 (GLOBE NEWSWIRE) -- HealthLynked Corp. (OTCQB:HLYK) today announced the release of its new design with the introduction of its newsfeed service. The new design allows members to access the [...]

Dr. Brian O’Connor Joins Veritas Pharma Advisory Board

02/01/2018 - 09:05

VANCOUVER, British Columbia, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP ) , (“Veritas” or the “Company”) is pleased to announce that Dr. Brian O’Connor, a consultant in [...]

How assessURhealth™ worked to #EndTheStigma in 2017

01/01/2018 - 15:29

Tampa, Jan. 01, 2018 (GLOBE NEWSWIRE) -- assessURhealth, LLC , a leading provider of mental and behavioral health screening software, took their mission to new heights in 2017. Expanding their integration capabilities [...]

Veloxis Announces the Total Number of Shares and Voting Rights in the Company as of 31 December 2017

31/12/2017 - 18:00

Company Release no. 27/2017 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 31 December 2017 Veloxis Announces the Total Number of Shares and Voting Rights in the Company as of 31 December 2017 Veloxis Pharmaceuticals A/ [...]